# Filing Detail

Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001140361-22-016716
Filing Date
2022-04-29
Accepted
2022-04-29 06:05:15
Documents
6
Period of Report
2022-06-16

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | DEF 14A | ny20003245x1_def14a.htm | DEF 14A | 892046
2 |  | logo_pliant.jpg | GRAPHIC | 33501
3 |  | logo_pliantx1.jpg | GRAPHIC | 44873
4 |  | ny20003245x1-pc_1.jpg | GRAPHIC | 558900
5 |  | ny20003245x1-pc_2.jpg | GRAPHIC | 490361
6 |  | sig_mouimette.jpg | GRAPHIC | 18498
| Complete submission text file | 0001140361-22-016716.txt |  | 2470384

Mailing Address 260 LITTLEFIELD AVENUE SOUTH SAN FRANCISCO CA 94080
Business Address 260 LITTLEFIELD AVENUE SOUTH SAN FRANCISCO CA 94080 650-481-6770
PLIANT THERAPEUTICS, INC. (Filer) CIK: 0001746473 (see all company filings)

EIN.: 474272481 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-39303 | Film No.: 22869831
SIC: 2834 Pharmaceutical Preparations